Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary complement factor H in renal disease.

Mariko Tamano1, Yoshinobu Fuke, Morito Endo

  • 1Division of Nephrology, Internal Medicine II, Nihon University School of Medicine, Tokyo, Japan.

Nephron
|October 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis.

Advances in therapy·2026
Same author

Changes in tobacco sales before, during, and after the COVID-19 pandemic in Japan: An interrupted time series analysis.

PloS one·2026
Same author

Recurrent C3 glomerulopathy after prolonged remission.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Orai1- and STIM1-mediated calcium signaling controls PD-L1 expression and modulates antitumor immunity in oral cancer.

The journal of physiological sciences : JPS·2026
Same author

Corrigendum to Transcriptomic landscape of coexisting ovarian clear cell carcinoma and endometriosis: Insights into malignant transformation <[Cancer Treatment and Research Communications volume 46 (2026) 101098]>.

Cancer treatment and research communications·2026
Same author

EP4 stimulation promotes cell adhesion and migration via IL-6 signaling in oral squamous cell carcinoma.

The journal of physiological sciences : JPS·2026
Same journal

The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine.

Nephron·2026
Same journal

Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

Nephron·2026
Same journal

Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

Nephron·2026
Same journal

Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

Nephron·2026
Same journal

Prevalence of COVID-19 Pneumonia and Clinical Characteristics in Hemodialysis Patients During the SARS-CoV-2 Omicron Pandemic.

Nephron·2026
Same journal

Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

Nephron·2026
See all related articles

Elevated urinary complement factor H (U-hCFH) indicates kidney damage in nephritis patients. This finding suggests U-hCFH may serve as a novel biomarker for renal disease progression and severity.

Area of Science:

  • Nephrology
  • Immunology
  • Complement System Biology

Background:

  • Complement factor H (CFH) is crucial for regulating the alternative complement pathway.
  • Investigating urinary CFH (U-hCFH) as a potential indirect marker for renal damage.

Purpose of the Study:

  • To assess the diagnostic utility of U-hCFH levels in patients with various renal diseases.
  • To establish reference ranges for U-hCFH and correlate findings with clinical parameters.

Main Methods:

  • Urine samples collected from 104 renal disease patients.
  • U-hCFH levels quantified using the BTA TRAK Assay Kit.
  • Analysis included patients with nephritis, chronic renal failure, lupus nephritis, and other glomerular diseases.

Main Results:

Related Experiment Videos

  • U-hCFH levels were significantly elevated in 62 nephritis patients compared to normal ranges.
  • Higher U-hCFH levels observed in chronic renal failure, lupus nephritis, and glomerulonephritis compared to IgA nephropathy.
  • Elevated U-hCFH correlated with urinary protein and N-acetyl-beta-D-glucosaminidase, indicating tubular damage.

Conclusions:

  • Urinary complement factor H is detectable in patients with nephritis.
  • U-hCFH shows promise as a biomarker for renal damage and disease activity.